PHK
DOVA

Point72 Hong Kong’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Point72 Hong Kong’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,456
Closed -$11K – 1410
2018
Q4 		$11K Buy
+1,456
New +$23.4K 0.01% 542
2017
Q3 		– Sell
-3,974
Closed -$89K – 1171
2017
Q2 		$89K Buy
+3,974
New +$83.7K 0.09% 122

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Hong Kong's DOVA Position: Q1 2019 in Review

Point72 Hong Kong sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q1 2019, closing a stake of 1,456 shares — an estimated $11K sold.

Point72 Hong Kong first reported a position in DOVA in Q2 2017 and held it in 2 quarters. The position peaked at $89K in Q2 2017. 59 funds tracked by Wall St. Rank hold DOVA as of Q1 2019.

  • Point72 Hong Kong reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Point72 Hong Kong sold 1,456 Dova Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $11K.
  • Point72 Hong Kong first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • Point72 Hong Kong's Dova Pharmaceuticals, Inc. Common Stock position peaked at $89K in Q2 2017.
  • 59 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on Point72 Hong Kong's 13F filing for Q1 2019, filed 15 May 2019.